| abstract |
(57) [Summary]nMethods are provided for a) oral absorption of GLP-1 peptides conjugated to surfactants and b) long term storage of formulations containing these peptides. For example, the GLP-1 / DSS conjugate is administered orally instead of parenterally, which is more convenient for diabetics or other GLP-1 treated patients, and thereby provides patient compliance. It will be easier. |